Show simple item record

dc.contributor.authorTell, Grethe S.
dc.contributor.authorFrøyland, Livar
dc.contributor.authorHaugen, Margaretha
dc.contributor.authorHolvik, Kristin
dc.contributor.authorLøvik, Martinus
dc.contributor.authorStrand, Tor A
dc.contributor.authorIversen, Per Ole
dc.coverage.spatialNorwaynb_NO
dc.date.accessioned2018-04-27T11:26:07Z
dc.date.available2018-04-27T11:26:07Z
dc.date.created2017-10-19T09:17:45Z
dc.date.issued2016
dc.identifier.isbn978-82-8259-197-3
dc.identifier.urihttp://hdl.handle.net/11250/2496375
dc.description.abstractThe Norwegian Scientific Committee for Food Safety (VKM) has, at the request of the Norwegian Food Safety Authority, assessed the risk of specified doses of L-arginine and arginine alpha-ketoglutarate in food supplements. VKM concludes that:  In adults (≥18 years), the specified doses of 3000, 3500, 4000, 4500, 5000, 5500 and 6000 mg/day of arginine in food supplements are considered unlikely to cause adverse health effects. The dose 6800 mg/day may represent a risk of adverse health effects.  In adolescents (14 to <18 years), the specified doses 3000, 3500, 4000, 4500, 5000, 5500 mg/day L-arginine in food supplements are considered unlikely to cause adverse health effects, whereas the doses 6000 and 6800 mg/day may represent a risk of adverse health effects.  In children (10 to <14 years), the specified doses 3000 and 3500 mg/day L-arginine in food supplements are considered unlikely to cause adverse health effects, whereas the doses 4000, 4500, 5000, 5500, 6000 and 6800 mg/day may represent a risk of adverse health effect. No dosage of arginine alpha-ketoglutarate in food supplements can be evaluated, due to lack of data.nb_NO
dc.language.isoengnb_NO
dc.publisherNorwegian Committee for Food Safetynb_NO
dc.relation.ispartofVKM Report
dc.relation.ispartofseriesVKM Report;
dc.relation.urihttps://vkm.no/download/18.645b840415d03a2fe8f26066/1502798687898/8b62ea4db0.pdf
dc.rightsNavngivelse-Ikkekommersiell-DelPåSammeVilkår 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/deed.no*
dc.subjectAdverse health effectnb_NO
dc.subjectnegative health effectnb_NO
dc.subjectNorwegian Scientific Committee for Food Safetynb_NO
dc.subjectNorwegian Food Safety Authoritynb_NO
dc.subjectother substancesnb_NO
dc.subjectrisk assessmentnb_NO
dc.subjectVKMnb_NO
dc.subjectL-argininenb_NO
dc.subjectarginine alpha-ketoglutaratenb_NO
dc.subjectfood supplementnb_NO
dc.titleRisk assessment of "other substances" - L-arginine and arginine alpha-ketoglutarate. Opinion of the Panel on Nutrition, Dietetic Products, Novel Food and Allergy of the Norwegian Scientific Committee for Food Safetynb_NO
dc.typeResearch reportnb_NO
dc.description.versionpublishedVersionnb_NO
dc.source.pagenumber47nb_NO
dc.source.issue2016: 07nb_NO
dc.identifier.cristin1505773
cristin.unitcode1991,0,0,0
cristin.unitnameSykehuset Innlandet HF
cristin.ispublishedtrue
cristin.fulltextoriginal


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse-Ikkekommersiell-DelPåSammeVilkår 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse-Ikkekommersiell-DelPåSammeVilkår 4.0 Internasjonal